Mazapertine

Mazapertine is an antipsychotic medication that belongs to the class of atypical antipsychotics. It is primarily used in the treatment of schizophrenia and other psychotic disorders. Mazapertine is known for its unique pharmacological profile, which includes a combination of dopamine and serotonin receptor antagonism.
Pharmacology[edit]
Mazapertine acts on multiple neurotransmitter systems in the brain. It primarily functions as an antagonist at the dopamine D2 receptors and serotonin 5-HT2A receptors. This dual action is believed to contribute to its efficacy in reducing both positive and negative symptoms of schizophrenia.
Mechanism of Action[edit]
The mechanism of action of Mazapertine involves blocking the dopamine D2 receptors, which helps in reducing the overactivity of dopamine that is often associated with psychotic symptoms. Additionally, its antagonistic effect on serotonin 5-HT2A receptors helps in modulating mood and cognitive functions, which can be beneficial in treating the negative symptoms of schizophrenia.
Indications[edit]
Mazapertine is indicated for the treatment of:
- Schizophrenia
- Bipolar disorder (off-label use)
- Other psychotic disorders
Side Effects[edit]
Common side effects of Mazapertine include:
Less common but more serious side effects may include:
Dosage and Administration[edit]
Mazapertine is typically administered orally. The dosage varies depending on the severity of the condition being treated and the patient's response to the medication. It is important to follow the prescribing physician's guidelines and adjust the dosage as necessary.
Contraindications[edit]
Mazapertine is contraindicated in patients with:
- Known hypersensitivity to Mazapertine or any of its components
- Severe liver disease
- Severe kidney disease
Interactions[edit]
Mazapertine may interact with other medications, including:
- Other antipsychotics
- Antidepressants
- Antihypertensive drugs
- CYP3A4 inhibitors
Research and Development[edit]
Mazapertine is still under investigation for its full range of therapeutic effects and potential new indications. Ongoing research aims to better understand its long-term efficacy and safety profile.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian